CANADA LIFE ASSURANCE Co - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 102 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
CANADA LIFE ASSURANCE Co ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$274
-62.7%
63,502
-42.9%
0.00%
-50.0%
Q2 2023$735
+0.5%
111,203
+3.3%
0.00%0.0%
Q1 2023$731
-9.1%
107,695
-0.8%
0.00%0.0%
Q4 2022$804
-99.9%
108,572
+72.7%
0.00%0.0%
Q3 2022$621,000
+2.1%
62,873
+12.8%
0.00%0.0%
Q2 2022$608,000
+8.4%
55,717
+15.2%
0.00%
+100.0%
Q1 2022$561,000
-26.0%
48,3680.0%0.00%
-50.0%
Q4 2021$758,000
-9.4%
48,368
-0.1%
0.00%0.0%
Q3 2021$837,000
-19.6%
48,4000.0%0.00%0.0%
Q2 2021$1,041,000
+49.8%
48,400
+4.5%
0.00%0.0%
Q1 2021$695,000
-2.7%
46,313
-14.8%
0.00%
+100.0%
Q4 2020$714,000
+23.7%
54,347
-9.2%
0.00%0.0%
Q3 2020$577,000
-24.5%
59,855
-10.3%
0.00%
-50.0%
Q2 2020$764,000
+6.0%
66,716
-4.5%
0.00%0.0%
Q1 2020$721,000
-33.9%
69,864
+4.2%
0.00%0.0%
Q4 2019$1,091,000
+10.6%
67,025
-4.2%
0.00%0.0%
Q2 2019$986,000
-23.4%
69,9880.0%0.00%
-33.3%
Q1 2019$1,287,000
-23.8%
69,9880.0%0.00%
-40.0%
Q4 2018$1,688,000
+1064.1%
69,988
+1008.8%
0.01%
Q3 2018$145,000
+20.8%
6,3120.0%0.00%
Q2 2018$120,000
-23.6%
6,312
-32.2%
0.00%
Q1 2018$157,000
+11.3%
9,3040.0%0.00%
Q4 2017$141,000
+193.8%
9,304
+244.6%
0.00%
Q3 2017$48,000
+9.1%
2,7000.0%0.00%
Q2 2017$44,000
+15.8%
2,7000.0%0.00%
Q1 2017$38,000
-11.6%
2,7000.0%0.00%
Q4 2016$43,000
-82.8%
2,700
-82.0%
0.00%
Q3 2016$250,000
+197.6%
15,000
+100.0%
0.00%
Q2 2016$84,000
+33.3%
7,5000.0%0.00%
Q1 2016$63,000
-10.0%
7,5000.0%0.00%
Q4 2015$70,000
-17.6%
7,5000.0%0.00%
Q3 2015$85,000
-10.5%
7,5000.0%0.00%
Q2 2015$95,000
+37.7%
7,5000.0%0.00%
Q1 2015$69,000
-35.5%
7,5000.0%0.00%
Q4 2014$107,000
+37.2%
7,5000.0%0.00%
Q3 2014$78,000
-35.5%
7,5000.0%0.00%
Q2 2014$121,0007,5000.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 728,000$10,425,0005.01%
Signpost Capital Advisors, LP 828,793$11,868,0004.38%
Palo Alto Investors LP 3,786,908$54,229,0003.18%
RTW INVESTMENTS, LP 500,000$7,160,0002.65%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,139,787$59,282,0002.13%
First Light Asset Management, LLC 229,818$3,291,0001.86%
KINGDON CAPITAL MANAGEMENT, L.L.C. 2,461,305$35,246,0001.53%
PURA VIDA INVESTMENTS, LLC 175,000$2,506,0000.92%
WALL STREET ASSOCIATES 655,800$9,391,0000.90%
SPHERA FUNDS MANAGEMENT LTD. 368,390$5,275,0000.90%
View complete list of VANDA PHARMACEUTICALS INC shareholders